INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 215 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,172 | -30.4% | 90,416 | -20.1% | 0.00% | -100.0% |
| Q2 2023 | $50,538 | +43.6% | 113,188 | +401.8% | 0.00% | 0.0% |
| Q4 2022 | $35,189 | -59.6% | 22,557 | -54.9% | 0.00% | -66.7% |
| Q2 2022 | $87,000 | -9.4% | 50,060 | +87.1% | 0.00% | 0.0% |
| Q1 2022 | $96,000 | -39.6% | 26,756 | +55.8% | 0.00% | -66.7% |
| Q1 2021 | $159,000 | – | 17,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 581,100 | $2,324,000 | 2.21% |
| Round Table Services, LLC | 339,391 | $1,358,000 | 0.52% |
| ARK Investment Management | 1,885,641 | $7,543,000 | 0.31% |
| WASATCH ADVISORS LP | 5,337,930 | $21,352,000 | 0.28% |
| Cedar Brook Financial Partners, LLC | 41,500 | $166,000 | 0.10% |
| Unified Trust Company, N.A. | 13,716 | $54,000 | 0.05% |
| Virtus ETF Advisers LLC | 60,398 | $242,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 394,703 | $1,579,000 | 0.04% |
| FOX RUN MANAGEMENT, L.L.C. | 14,465 | $58,000 | 0.03% |
| BREWIN DOLPHIN LTD | 59,123 | $236,492 | 0.03% |